Clinical Trial
doi: 10.1056/NEJMoa0802268. Epub 2008 Apr 27.Effect of gene therapy on visual function in Leber's congenital amaurosis
James W B Bainbridge 1, Alexander J Smith, Susie S Barker, Scott Robbie, Robert Henderson, Kamaljit Balaggan, Ananth Viswanathan, Graham E Holder, Andrew Stockman, Nick Tyler, Simon Petersen-Jones, Shomi S Bhattacharya, Adrian J Thrasher, Fred W Fitzke, Barrie J Carter, Gary S Rubin, Anthony T Moore, Robin R Ali
Affiliations
- PMID:18441371
- DOI: 10.1056/NEJMoa0802268
Item in Clipboard
Clinical Trial
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W B Bainbridge et al. N Engl J Med..
Free article Display options
Format
Display options
Format
Abstract
Early-onset, severe retinal dystrophy caused by mutations in the gene encoding retinal pigment epithelium-specific 65-kD protein (RPE65) is associated with poor vision at birth and complete loss of vision in early adulthood. We administered to three young adult patients subretinal injections of recombinant adeno-associated virus vector 2/2 expressing RPE65 complementary DNA (cDNA) under the control of a human RPE65 promoter. There were no serious adverse events. There was no clinically significant change in visual acuity or in peripheral visual fields on Goldmann perimetry in any of the three patients. We detected no change in retinal responses on electroretinography. One patient had significant improvement in visual function on microperimetry and on dark-adapted perimetry. This patient also showed improvement in a subjective test of visual mobility. These findings provide support for further clinical studies of this experimental approach in other patients with mutant RPE65. (ClinicalTrials.gov number,NCT00643747 [ClinicalTrials.gov].).
Copyright 2008 Massachusetts Medical Society.
Comment in
- Preliminary results of gene therapy for retinal degeneration.Miller JW.Miller JW.N Engl J Med. 2008 May 22;358(21):2282-4. doi: 10.1056/NEJMe0803081. Epub 2008 Apr 27.N Engl J Med. 2008.PMID:18441372No abstract available.
Similar articles
- Safety and efficacy of gene transfer for Leber's congenital amaurosis.Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J.Maguire AM, et al.N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.N Engl J Med. 2008.PMID:18441370Free PMC article.Clinical Trial.
- Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.Rolling F, Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F.Rolling F, et al.Bull Mem Acad R Med Belg. 2006;161(10-12):497-508; discussion 508-9.Bull Mem Acad R Med Belg. 2006.PMID:17503728
- Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F.Le Meur G, et al.Gene Ther. 2007 Feb;14(4):292-303. doi: 10.1038/sj.gt.3302861. Epub 2006 Oct 5.Gene Ther. 2007.PMID:17024105
- Gene therapy for vision loss -- recent developments.Stieger K, Lorenz B.Stieger K, et al.Discov Med. 2010 Nov;10(54):425-33.Discov Med. 2010.PMID:21122474Review.
- Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.Stein L, Roy K, Lei L, Kaushal S.Stein L, et al.Expert Opin Biol Ther. 2011 Mar;11(3):429-39. doi: 10.1517/14712598.2011.557358.Expert Opin Biol Ther. 2011.PMID:21299439Review.
Cited by
- Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.Boye SE, Alexander JJ, Witherspoon CD, Boye SL, Peterson JJ, Clark ME, Sandefer KJ, Girkin CA, Hauswirth WW, Gamlin PD.Boye SE, et al.Hum Gene Ther. 2016 Aug;27(8):580-97. doi: 10.1089/hum.2016.085.Hum Gene Ther. 2016.PMID:27439313Free PMC article.
- Retinoid therapy restores eye-specific cortical responses in adult mice with retinal degeneration.Huh CYL, Leinonen H, Nakayama T, Tomasello JR, Zhang J, Zeitoun J, Peach JP, Halabi M, Kiser JZ, Palczewski K, Kiser PD, Gandhi SP.Huh CYL, et al.Curr Biol. 2022 Oct 24;32(20):4538-4546.e5. doi: 10.1016/j.cub.2022.09.005. Epub 2022 Sep 23.Curr Biol. 2022.PMID:36152631Free PMC article.
- Treated PDR Reveals Age-Appropriate Vision Deterioration But Distorted Retinal Organization.Chen XD, Omari A, Hwang M, Kwark L, Dakki N, Farsiu S, Gardner TW.Chen XD, et al.Transl Vis Sci Technol. 2020 Feb 7;9(3):3. doi: 10.1167/tvst.9.3.3.Transl Vis Sci Technol. 2020.PMID:32704423Free PMC article.
- Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho(-/-) mouse.Palfi A, Chadderton N, O'Reilly M, Nagel-Wolfrum K, Wolfrum U, Bennett J, Humphries P, Kenna P, Millington-Ward S, Farrar J.Palfi A, et al.Mol Ther Methods Clin Dev. 2015 May 6;2:15016. doi: 10.1038/mtm.2015.16. eCollection 2015.Mol Ther Methods Clin Dev. 2015.PMID:26029727Free PMC article.
- Improvement and decline in vision with gene therapy in childhood blindness.Jacobson SG, Cideciyan AV, Roman AJ, Sumaroka A, Schwartz SB, Heon E, Hauswirth WW.Jacobson SG, et al.N Engl J Med. 2015 May 14;372(20):1920-6. doi: 10.1056/NEJMoa1412965. Epub 2015 May 3.N Engl J Med. 2015.PMID:25936984Free PMC article.Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases